Book tickets for Pivotal Links 2024, Oxford UK, 17-18th June 2024

Our Portfolio

Pivotal Scientific Limited is pleased to have supported 2BScientific Limited as they enter an asset purchase agreement with Newmarket Scientific Limited by providing M&A advisory services and leading the process to identify, engage and complete the transaction. On behalf of 2BScientific Limited, Pivotal Scientific Limited completed a full review of the Newmarket Scientific Limited business, allowing 2BScientific Limited to effectively assess the opportunity. Pivotal Scientific Limited provided the recommendation to enter into agreement with Newmarket Scientific Limited after identifying the shared client base of both…

2b Newmarket

Our unique team of consultants offer a wealth of expertise across different fields gained from experience in both the scientific and commercial marketplaces. With an expanding portfolio of successful projects our knowledge base continues to grow along with our confidence to offer the best advice ensuring you achieve the most desirable business outcomes. Below are some of our most recent projects:

Parel Llc Percorso Web

Percorso acquired by Parel Bio, LLC 

6th November, London, UK – Life Science Logistics firm Percorso Life Sciences today announced their acquisition by Parel Bio, LLC.  Pivotal Scientific Limited (PSL) exclusively…

Read More »

Lgc Acquires Virusys

Virusys Corporation acquired by LGC

Virusys approached Pivotal Scientific Limited (PSL) to exclusively manage the sale of the company, having been recommended…

Read More »

Fortis Abcore

Abcore is Acquired by Fortis Life Sciences

Abcore approached Pivotal Scientific to exclusively manage the sale of the company to Fortis Life Sciences, trusting our previous support and recognizing our skills in M&A…

Read More »

Chromocyte Biocompare2

Chromocyte is Acquired by Biocompare

The Chromocyte Journey from startup to maturity to acquisition: Pivotal Scientific has assisted Chromocyte throughout its business lifecycle. We are delighted to have supported it…

Read More »

Arlington Scientific acquires non-mammalian blocking buffer product line from Clark McDermith

Pivotal Scientific are pleased to announce their involvement in Arlington Scientific, Inc. acquiring the non-mammalian blocking buffer product line from Clark McDermith, former owner of East…

Read More »

Atlas

Pivotal Scientific advises Atlas Antibodies on its purchase of Evitria

Pivotal Scientific Limited supported Atlas Antibodies in their decision making on the purchase of Evitria by undertaking commercial due diligence and providing expert advisory services. Atlas Antibodies wanted to make…

Read More »

Nordic Scicons

Pivotal Scientific advises Nordic-MUbio on its purchase of SCICONS

Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Hungarian based Biotechnology company SCICONS to Nordic MUbio based in the…

Read More »

Lsbio Abab

Pivotal Scientific advises Absolute Antibody on its sale to LSBio

Pivotal Scientific are delighted to have advised the shareholders of Absolute Antibody, Ltd. (UK) and its sister company Kerafast on their sale to LSBio (USA)….

Read More »

Clinisciences Antibodybcn

Pivotal Scientific advises Antibody BCN on its sale to CliniSciences

CliniSciences adds to its portfolio of companies Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Spanish based Biotechnology company AbBcn…

Read More »

Lsbio Everest

LifeSpan BioSciences, Inc. announces the acquisition of Everest Biotech

Release Date: July 31st, 2019 Seattle, Washington State, USA– June 2019 – LifeSpan BioSciences (LSBio), a leading provider of antibodies and life science research reagents…

Read More »

Medix Eastcoast

Pivotal Scientific advises EastCoast Bio on its sale to Medix Biochemica

A successful transaction benefitting both parties. Pivotal Scientific is delighted to announce its assistance in the sale of US-based biotech firm EastCoast Bio to the…

Read More »